Kutatási jelek – Signal Engine

• Molecular docking and dynamics reveal novel CDK6 inhibitors for targeted glioblastoma therapy — Diffuse large B-cell lymphoma
• Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025 — Waldenstrom macroglobulinemia
• A single‑center retrospective study suggests a potential benefit of BTK inhibitor‑based therapy in patients with histologic transformation of Waldenström macroglobulinemia — Diffuse large B-cell lymphoma
• Cost-effectiveness of zanubrutinib versus ibrutinib as first-line treatment for patients with Waldenström macroglobulinemia in China — Waldenstrom macroglobulinemia
• New perspective on epigenetic modification and immunotherapy in endometrial cancer — Endometrial cancer
• Proteogenomic profiling defines progression-associated biology in high-risk endometrial cancer — Endometrial cancer
• Fertility-preserving treatment for endometrial atypical hyperplasia and endometrial cancer: a systematic review and meta-analysis — Endometrial cancer
• Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study — Endometrial cancer
• Unlocking personalized endometrial cancer treatment: the critical role of the BBIRE biobank in sample collection and distribution — Endometrial cancer
• Evaluation of Punicalagin as a multi-targeted therapeutic agent against endometrial cancer — Endometrial cancer
• Impact of Molecular Classification on Multidisciplinary Treatment Decision Making in Early-Stage Endometrial Cancer: A Prospective Real-World Study From India. — Endometrial cancer
• Information experiences among women diagnosed with endometrial cancer: a mixed methods study — Endometrial cancer
• Frontiers | Does immunotherapy hold great promise in endometrial cancer care? — Endometrial cancer
• Chemotherapy combined with immunotherapy vs. chemotherapy: comparison of safety and efficacy in adjuvant therapy for intrahepatic cholangiocarcinoma — Cholangiocarcinoma
• Updated on the clinical features, treatment and histogenesis of combined hepatocellular‑cholangiocarcinoma — Cholangiocarcinoma
• Real-World Treatment Patterns and Early Outcomes in Advanced Intrahepatic Cholangiocarcinoma: A Descriptive Case Series — Cholangiocarcinoma
• Effect of Case Discussion with Expert Centers on Treatment Outcome of Intrahepatic Cholangiocarcinoma — Cholangiocarcinoma
• Betulinic Acid Extracted from Guava (Psidium guajava L.) Leaves Inhibits Human Cholangiocarcinoma Cell Metastasis by Activating E-cadherin and Inhibiting MMP-9 and VEGF — Cholangiocarcinoma
• KRAS/ERK2-driven stabilization of AARS1 reprograms tumor metabolism and confers Sorafenib resistance in lung adenocarcinoma — NSCLC
• Targeting TROP2 in treatment‑resistant non‑small cell lung cancer harboring the KRAS G12C mutation and TROP2 upregulation: A case report — NSCLC